Phase 2 Ablation Clinical Trials

2 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–2 of 2 trials

Recruiting

Phase 2

Clinical Study on the Effectiveness and Safety of Lenvatinib As Adjuvant Treatment for Patients with High-risk Recurrence of Hepatocellular Carcinoma After Surgery

Hepatocellular Carcinoma (HCC)Adjuvant Therapy in Patients with Hepatocellular Carcinoma (HCC) At High Risk of Recurrence After Curative Resection or Ablation

The First Affiliated Hospital with Nanjing Medical University276 enrolled1 locationNCT06762782

Recruiting

Phase 2

RFA Plus Carrizumab vs Carrizumab Alone for HCC

Radiofrequency AblationTumor ImmunityImmunosuppression

Second Affiliated Hospital, School of Medicine, Zhejiang University120 enrolled1 locationNCT04150744